European Society of Gynaecological Oncology (ESGO) shared the post on LinkedIn:
“Why was the TRUST trial conducted? Sven Mahner on the rationale behind the study:
“A trial built on strict quality criteria to achieve high resection rates in operable cases.”
Watch the full conversation with Sven Mahner and Christina Fotopoulou Fotopoulou on ESGO eAcademy.
More on the TRUST trial.”
More posts featuring European Society of Gynaecological Oncology.